We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
+10.07%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$419M
AUM Growth
+$148M
Cap. Flow
+$129M
Cap. Flow %
30.92%
Top 10 Hldgs %
12.65%
Holding
735
New
336
Increased
76
Reduced
46
Closed
277

Top Sells

Rank Stock Value
1
NKE icon
Nike
NKE
+$9.64M
2
AYI icon
Acuity Brands
AYI
+$4.57M
3
MDLZ icon
Mondelez International
MDLZ
+$3.38M
4
COST icon
Costco
COST
+$2.98M
5
INTU icon
Intuit
INTU
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 17.55%
2 Consumer Discretionary 17.53%
3 Healthcare 13.84%
4 Industrials 10.3%
5 Consumer Staples 10.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
101
Gilead Sciences
GILD
$163B
$1.24M 0.3%
+15,300
New +$1.17M
TSS
102
DELISTED
Total System Services, Inc.
TSS
$1.24M 0.3%
18,900
+1,300
+7% +$84K
WMGI
103
DELISTED
Wright Medical Group Inc
WMGI
$1.23M 0.29%
+47,400
New +$1.31M
LOGM
104
DELISTED
LogMein, Inc.
LOGM
$1.22M 0.29%
11,100
+4,500
+68% +$505K
NEM icon
105
Newmont
NEM
$98.4B
$1.21M 0.29%
+32,200
New +$1.17M
H icon
106
Hyatt Hotels
H
$18B
$1.21M 0.29%
+19,500
New +$1.13M
CINF icon
107
Cincinnati Financial
CINF
$28.5B
$1.2M 0.29%
+15,700
New +$1.19M
ATH
108
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$1.2M 0.29%
+22,300
New +$1.15M
ZAYO
109
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$1.19M 0.29%
+34,700
New +$1.15M
PDCO
110
DELISTED
Patterson Companies, Inc.
PDCO
$1.19M 0.28%
+30,700
New +$1.23M
FCX icon
111
Freeport-McMoran
FCX
$89.1B
$1.19M 0.28%
+84,400
New +$1.19M
ACHC icon
112
Acadia Healthcare
ACHC
$2.98B
$1.18M 0.28%
+24,600
New +$1.2M
MSFT icon
113
Microsoft
MSFT
$2.92T
$1.17M 0.28%
15,700
-7,691
-33% -$562K
FUL icon
114
H.B. Fuller
FUL
$3.03B
$1.17M 0.28%
+20,089
New +$1.05M
STE icon
115
Steris
STE
$21.3B
$1.16M 0.28%
+13,119
New +$1.11M
CPRI icon
116
Capri Holdings
CPRI
$1.81B
$1.14M 0.27%
+23,822
New +$968K
ANET icon
117
Arista Networks
ANET
$217B
$1.14M 0.27%
+96,000
New +$1M
NVS icon
118
Novartis
NVS
$298B
$1.13M 0.27%
14,650
+10,156
+226% +$767K
BF.B icon
119
Brown-Forman Class B
BF.B
$12.5B
$1.13M 0.27%
+32,414
New +$1.05M
BTI icon
120
British American Tobacco
BTI
$131B
$1.12M 0.27%
+17,900
New +$1.15M
ADM icon
121
Archer Daniels Midland
ADM
$40.1B
$1.11M 0.27%
+26,191
New +$1.1M
PZZA icon
122
Papa John's
PZZA
$1.02B
$1.09M 0.26%
+14,900
New +$1.12M
TFCFA
123
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$1.08M 0.26%
+40,800
New +$1.12M
DATA
124
DELISTED
Tableau Software, Inc.
DATA
$1.07M 0.26%
14,316
+2,700
+23% +$187K
GRMN
125
Garmin
GRMN
$46.6B
$1.07M 0.26%
+19,800
New +$1.03M

Similar funds

Bayesian Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Bayesian Capital Management held 735 positions worth $419M, up 54% from $271M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Bayesian Capital Management deployed $129M of net new capital in Q3 2017, opening 336 new positions and adding to 76 existing holdings. Its largest new stake was Accenture: 53,319 shares worth $7.2M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Vodafone, an estimated $1.72M trimmed.

  • Bayesian Capital Management's largest Q3 2017 buy was Accenture: 53,319 shares worth $7.2M.
  • Bayesian Capital Management added most to Rockwell Collins in Q3 2017, an estimated $5.18M increase.
  • Bayesian Capital Management's biggest Q3 2017 reduction was Vodafone, cutting an estimated $1.72M.
  • Bayesian Capital Management fully exited Nike in Q3 2017, selling an estimated $9.64M.
  • Bayesian Capital Management's ten largest holdings make up 13% of its $419M portfolio in Q3 2017.
  • Bayesian Capital Management opened 336 new positions and closed 277 in Q3 2017.
  • Bayesian Capital Management's portfolio value rose 54% quarter-over-quarter to $419M.

Based on Bayesian Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.